194 employees
Nordic Bioscience is dedicated to preclinical and clinical drug development, specializing in personalized medicine using unique biomarker.
1991
$100M
from 1 investors over 1 rounds
Nordic Bioscience A/S raised $100M on March 3, 2021
Investors: KKR & Co. Inc.